title: Pleiotropic mechanisms facilitated by resveratrol and its metabolites.
abstract: Resveratrol has demonstrated cancer chemopreventive activity in animal models and some clinical trials are underway. In addition, resveratrol was shown to promote cell survival, increase lifespan and mimic caloric restriction, thereby improving health and survival of mice on high-calorie diet. All of these effects are potentially mediated by the pleiotropic interactions of resveratrol with different enzyme targets including COX-1 (cyclo-oxygenase-1) and COX-2, NAD+-dependent histone deacetylase SIRT1 (sirtuin 1) and QR2 (quinone reductase 2). Nonetheless, the health benefits elicited by resveratrol as a direct result of these interactions with molecular targets have been questioned, since it is rapidly and extensively metabolized to sulfate and glucuronide conjugates, resulting in low plasma concentrations. To help resolve these issues, we tested the ability of resveratrol and its metabolites to modulate the function of some known targets in vitro. In the present study, we have shown that COX-1, COX-2 and QR2 are potently inhibited by resveratrol, and that COX-1 and COX-2 are also inhibited by the resveratrol 4'-O-sulfate metabolite. We determined the X-ray structure of resveratrol bound to COX-1 and demonstrate that it occupies the COX active site similar to other NSAIDs (non-steroidal anti-inflammatory drugs). Finally, we have observed that resveratrol 3- and 4'-O-sulfate metabolites activate SIRT1 equipotently to resveratrol, but that activation is probably a substrate-dependent phenomenon with little in vivo relevance. Overall, the results of this study suggest that in vivo an interplay between resveratrol and its metabolites with different molecular targets may be responsible for the overall beneficial health effects previously attributed only to resveratrol itself.
authors.affiliation: Department of Medicinal Chemistry and Pharmacognosy and Center for Pharmaceutical Biotechnology, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, USA. b-calamini@northwestern.edu
authors.forename: Barbara
authors.initials: B
authors.lastname: Calamini
authors.forename: Kiira
authors.initials: K
authors.lastname: Ratia
authors.forename: Michael G
authors.initials: MG
authors.lastname: Malkowski
authors.forename: Muriel
authors.initials: M
authors.lastname: Cuendet
authors.forename: John M
authors.initials: JM
authors.lastname: Pezzuto
authors.forename: Bernard D
authors.initials: BD
authors.lastname: Santarsiero
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Mesecar
mesh_terms: D000818:Animals; D016588:Anticarcinogenic Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D020134:Catalytic Domain; D018360:Crystallography, X-Ray; D051545:Cyclooxygenase 1 / Q000737:chemistry / Q000378:metabolism; D051546:Cyclooxygenase 2 / Q000737:chemistry / Q000378:metabolism; D052246:Cyclooxygenase 2 Inhibitors / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D051379:Mice; D008958:Models, Molecular; D011808:Quinone Reductases / Q000037:antagonists & inhibitors; D000077185:Resveratrol; D056564:Sirtuin 1 / Q000378:metabolism; D013267:Stilbenes / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology*
chemical_list: D016588:Anticarcinogenic Agents; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D013267:Stilbenes; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; C419642:NRH - quinone oxidoreductase2; D011808:Quinone Reductases; C447939:SIRT1 protein, human; D056564:Sirtuin 1; D000077185:Resveratrol
references.citation: Mol Carcinog. 2008 Oct;47(10):797-805
references.pmid: 18381589
references.citation: Biochemistry. 2004 Sep 14;43(36):11417-26
references.pmid: 15350128
references.citation: Free Radic Biol Med. 2008 Jul 15;45(2):136-45
references.pmid: 18423413
references.citation: J Biol Chem. 2010 Mar 12;285(11):8340-51
references.pmid: 20061378
references.citation: Nat Protoc. 2006;1(4):1915-21
references.pmid: 17487176
references.citation: J Biol Chem. 2005 Mar 18;280(11):9780-5
references.pmid: 15640142
references.citation: Biochemistry. 2004 Apr 20;43(15):4538-47
references.pmid: 15078100
references.citation: J Pharm Pharmacol. 2003 Mar;55(3):307-12
references.pmid: 12724035
references.citation: J Mol Biol. 1982 Oct 25;161(2):269-88
references.pmid: 7154081
references.citation: Chem Biol Drug Des. 2009 Dec;74(6):619-24
references.pmid: 19843076
references.citation: Arch Biochem Biophys. 2000 Aug 1;380(1):39-45
references.pmid: 10900130
references.citation: Nature. 2007 Nov 29;450(7170):712-6
references.pmid: 18046409
references.citation: Prostaglandins Other Lipid Mediat. 1998 Jun;56(2-3):131-43
references.pmid: 9785383
references.citation: Drugs Exp Clin Res. 1999;25(2-3):115-20
references.pmid: 10370873
references.citation: Nature. 2003 Nov 13;426(6963):119
references.pmid: 14614475
references.citation: Nature. 2003 Sep 11;425(6954):191-6
references.pmid: 12939617
references.citation: Clin Chim Acta. 1995 Jun 15;237(1-2):155-87
references.pmid: 7664473
references.citation: Biochem Biophys Res Commun. 2004 Oct 22;323(3):743-9
references.pmid: 15381063
references.citation: Science. 2000 Sep 15;289(5486):1933-7
references.pmid: 10988074
references.citation: Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
references.pmid: 9757107
references.citation: Nucleic Acids Res. 2000 Jan 1;28(1):235-42
references.pmid: 10592235
references.citation: Methods Enzymol. 1997;276:307-26
references.pmid: 27754618
references.citation: J Biol Chem. 1998 Aug 21;273(34):21875-82
references.pmid: 9705326
references.citation: Biochem J. 1999 May 1;339 ( Pt 3):607-14
references.pmid: 10215599
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):182-7
references.pmid: 17097357
references.citation: Rapid Commun Mass Spectrom. 2003;17(4):307-13
references.pmid: 12569440
references.citation: Biochemistry. 1999 Dec 14;38(50):16636-47
references.pmid: 10600126
references.citation: Acta Crystallogr A. 1991 Mar 1;47 ( Pt 2):110-9
references.pmid: 2025413
references.citation: J Biol Chem. 2005 Apr 29;280(17):17038-45
references.pmid: 15684413
references.citation: Biochem Pharmacol. 2006 Jul 28;72(3):366-76
references.pmid: 16765324
references.citation: J Biol Chem. 2004 May 21;279(21):22727-37
references.pmid: 15020596
references.citation: Nature. 2006 Nov 16;444(7117):337-42
references.pmid: 17086191
references.citation: Clin Chim Acta. 1995 Mar 31;235(2):207-19
references.pmid: 7554275
references.citation: Cancer Res. 2000 Jul 1;60(13):3477-83
references.pmid: 10910059
references.citation: J Biol Chem. 2002 Nov 29;277(48):46131-9
references.pmid: 12351651
references.citation: Proc Natl Acad Sci U S A. 1975 Aug;72(8):3073-6
references.pmid: 810797
references.citation: Drug Metab Dispos. 2004 Dec;32(12):1377-82
references.pmid: 15333514
references.citation: Nat Biotechnol. 2010 Mar;28(3):185-6
references.pmid: 20212464
references.citation: Nature. 2004 Aug 5;430(7000):686-9
references.pmid: 15254550
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1246-52
references.pmid: 17548692
references.citation: Cancer Prev Res (Phila). 2008 Jul;1(2):135-45
references.pmid: 19138946
references.citation: Arch Biochem Biophys. 2000 Mar 1;375(1):195-200
references.pmid: 10683267
references.citation: Bioorg Med Chem. 2004 Nov 1;12(21):5571-8
references.pmid: 15465334
references.citation: Br J Cancer. 2006 Nov 6;95(9):1229-33
references.pmid: 17031400
references.citation: Science. 1997 Jan 10;275(5297):218-20
references.pmid: 8985016
references.citation: Biochem J. 2007 May 15;404(1):1-13
references.pmid: 17447894
references.citation: Cancer Res. 2000 Aug 1;60(15):4179-86
references.pmid: 10945627
references.citation: Pharm Res. 2002 Dec;19(12):1907-14
references.pmid: 12523673
references.citation: J Biol Chem. 2005 Apr 29;280(17):17187-95
references.pmid: 15749705
references.citation: Science. 1983 Aug 19;221(4612):709-13
references.pmid: 6879170